Although the PI3K pathway has been reported to harbor the highest percentage of mutations (30.5%) [5], widespread genomic and epigenetic alterations may account for the frequent activation of the PI3K/AKT/mTOR axis in HNSCC. The gene discussed is PIK3CA; the disease is head and neck squamous cell carcinoma.